Skip to main content
biotech

Biotech-Focused Hedge Funds Back Talawar’s Fast Moving SPAC Merger

RA Capital, Deep Track and other healthcare investors joined a $225 million PIPE supporting Talawar Therapeutics’ deal with JATT II, which found a merger partner just over two months after its IPO.

Stephen Taub

II Reveals More Nominees for the 2026 Allocators’ Choice Awards. Now It’s Time to Vote.

The finalists for Corporate Pension Plan CIO, Team of the Year, Allocator/Manager Partnership, and the award for Leadership and Vision are out now.

AI Is Making Even Tech Hedge Funds Look Like the S&P 500

PivotalPath’s data suggests AI concentration is no longer just reshaping benchmarks. It’s making it harder for even specialized tech investors to look meaningfully different from the market itself.
Julie Segal May 27, 2026